# Zinc suppresses Stat3-driven IL-6 production in primary mouse adipocytes

**Authors:** Hak Chung, John Eom, Michelle SMA Damen, Traci E. Stankiewicz, Keisuke Sawada, Pablo C. Alarcon, Cassidy J. Ulanowicz, Jennifer L. Wayland, George S. Deepe, Senad Divanovic

PMC · DOI: 10.3389/fimmu.2026.1714168 · Frontiers in Immunology · 2026-02-09

## TL;DR

Zinc reduces inflammation in fat cells by blocking a key signaling pathway that increases IL-6 production.

## Contribution

Zinc's novel inhibitory role in suppressing IL-6 production in non-immune adipocytes is revealed.

## Key findings

- Zinc pyrithione treatment reduces TLR ligand-driven IL-6 production in mouse adipocytes.
- Zinc suppresses Stat3 signaling and breaks the IL-6 autocrine feedback loop in adipocytes.
- Zinc inhibits expression of IL-6 and its receptor genes in adipocytes.

## Abstract

Uncontrolled inflammatory cytokine production promotes pathogenesis of various chronic diseases. Zinc (Zn) regulates immune cell inflammatory cytokine production. However, the influence of Zn on the inflammatory properties of non-immune cells known to contribute to disease pathogenesis is not well understood. Adipocytes respond to various immunological stimuli by activating inflammatory pathways and secreting inflammatory cytokines. Here, we investigated the impact of Zn on adipocyte inflammatory vigor. We show that treatment of primary mouse adipocytes with Zn, in the form of Zn pyrithione, restricted their toll-like receptor ligand-driven IL-6 production. Mechanistically, IL-6 secreted from adipocytes functions in an autocrine fashion to activate the Stat3 pathway and amplify IL-6 production via a positive feedback loop. Notably, Zn treatment of adipocytes suppressed Stat3 signaling activation to break the positive feedback loop and subsequent expression of IL-6 and its receptor genes (Il6st, Il6ra). Collectively, our findings uncover a novel inhibitory role for Zn in non-immune cell, specifically adipocyte, IL-6 production. These findings invoke a potential role of Zn in the regulation of adipocyte-associated chronic inflammation and disease pathogenesis.

## Linked entities

- **Genes:** IL6ST (interleukin 6 cytokine family signal transducer) [NCBI Gene 3572], IL6R (interleukin 6 receptor) [NCBI Gene 3570]
- **Proteins:** STAT3 (signal transducer and activator of transcription 3)
- **Chemicals:** Zinc (PubChem CID 23994)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, Slc30a1 (solute carrier family 30 (zinc transporter), member 1) [NCBI Gene 22782] {aka C130040I11Rik, Znt1}, Myd88 (myeloid differentiation primary response gene 88) [NCBI Gene 17874], Dusp5 (dual specificity phosphatase 5) [NCBI Gene 240672] {aka Gm337}, NR0B2 (nuclear receptor subfamily 0 group B member 2) [NCBI Gene 8431] {aka SHP, SHP1}, Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 14281] {aka D12Rfj1, c-fos, cFos}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, Il6ra (interleukin 6 receptor, alpha) [NCBI Gene 16194] {aka CD126, IL-6R, IL-6R-alpha, IL-6RA, Il6r}, Tlr3 (toll-like receptor 3) [NCBI Gene 142980], Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 20848] {aka 1110034C02Rik, Aprf}, SLC30A2 (solute carrier family 30 member 2) [NCBI Gene 7780] {aka PP12488, TNZD, ZNT2, ZnT-2}, Socs3 (suppressor of cytokine signaling 3) [NCBI Gene 12702] {aka Cis3, Cish3, EF-10, Ef10, SSI-3, Ssi3}, Bcl2l11 (BCL2 like 11) [NCBI Gene 12125] {aka 1500006F24Rik, Bim, Bod, bcl2-L-11}, STAT5A (signal transducer and activator of transcription 5A) [NCBI Gene 6776] {aka MGF, STAT5}, Bcl2 (B cell leukemia/lymphoma 2) [NCBI Gene 12043] {aka Bcl-2, C430015F12Rik, D630044D05Rik, D830018M01Rik}, Dusp4 (dual specificity phosphatase 4) [NCBI Gene 319520] {aka 2700078F24Rik, E130306H24Rik, MKP2}, EPHB2 (EPH receptor B2) [NCBI Gene 2048] {aka BDPLT22, CAPB, DRT, EK5, EPHT3, ERK}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, Atm (ataxia telangiectasia mutated) [NCBI Gene 11920] {aka C030026E19Rik}, Tyms (thymidylate synthase) [NCBI Gene 22171] {aka Ts}, Tlr2 (toll-like receptor 2) [NCBI Gene 24088] {aka Ly105}, Tlr5 (toll-like receptor 5) [NCBI Gene 53791], Il6st (interleukin 6 signal transducer) [NCBI Gene 16195] {aka 5133400A03Rik, CD130, D13Ertd699e, gp130}, Casp9 (caspase 9) [NCBI Gene 12371] {aka APAF-3, CASP-9, Caspase-9, ICE-LAP6, Mch6}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, Mtf1 (metal response element binding transcription factor 1) [NCBI Gene 17764] {aka MTF-1, Thyls}, Irak3 (interleukin-1 receptor-associated kinase 3) [NCBI Gene 73914] {aka 4833428C18Rik, IRAK-M}, Il2rg (interleukin 2 receptor, gamma chain) [NCBI Gene 16186] {aka CD132, [g]c, gamma(c), gc, p64}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Jun (Jun proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 16476] {aka AP-1, Junc, c-jun}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Cd247 (CD247 antigen) [NCBI Gene 12503] {aka 4930549J05Rik, A430104F18Rik, Cd3, Cd3-eta, Cd3-zeta, Cd3h}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}
- **Diseases:** systemic lupus erythematosus (MESH:D008180), atherosclerotic plaque (MESH:D058226), metabolic disorders (MESH:D008659), metabolic dysfunction-associated steatohepatitis (MESH:D005234), inflammatory bowel disease (MESH:D015212), obese (MESH:D009765), non-alcoholic steatohepatitis (MESH:D005235), weight loss (MESH:D015431), cytotoxicity (MESH:D064420), asthma (MESH:D001249), insulin resistance (MESH:D007333), atherosclerosis (MESH:D050197), arthritis (MESH:D001168), Chronic inflammation (MESH:D007249), metabolic syndrome (MESH:D024821), Zn (MESH:C564286)
- **Chemicals:** ethanol (MESH:D000431), glucose (MESH:D005947), DMSO (MESH:D004121), glycine (MESH:D005998), CaCl2 (MESH:D002122), Tween 20 (MESH:D011136), PBS (MESH:D007854), Laemmli buffer (MESH:C088816), SDS (MESH:D012967), Zinc pyrithione (MESH:C010423), PVDF (MESH:C024865), ZnSO4 (MESH:D019287), C188-9 (MESH:C000625861), LPS (MESH:D008070), CAPS (MESH:C097300), lipid (MESH:D008055), TRIzol (MESH:C411644), N,N,N',N'-tetrakis-(2-pyridylmethyl)ethylenediamine (MESH:C044387), water (MESH:D014867), Streptomycin (MESH:D013307), FITC (MESH:D016650), dexamethasone (MESH:D003907), ZnCl2 (MESH:C016837), Poly(I:C) (MESH:D011070), 3-Isobutyl-1-methylxanthine (MESH:D015056), PMA (MESH:D013755), F-12 (MESH:C007782), rosiglitazone (MESH:D000077154), Zinc (MESH:D015032), ionomycin (MESH:D015759), Penicillin (MESH:D010406), Pyrithione (MESH:C008704), metal (MESH:D008670), FluoZin-3 AM (-), Trypan Blue (MESH:D014343)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), HT-22 — Mus musculus (Mouse), Transformed cell line (CVCL_0321), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), MCF10A — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0598)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12926143/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12926143/full.md

## References

76 references — full list in the complete paper: https://tomesphere.com/paper/PMC12926143/full.md

---
Source: https://tomesphere.com/paper/PMC12926143